Glycemic Markers And Subclinical Cardiovascular Disease The Jackson Heart Study

This study examined the relationship between blood sugar control and early signs of heart disease in over 4,300 African American adults without existing cardiovascular disease. Researchers measured three key markers of blood sugar health: hemoglobin A1C (HbA1C, which shows average blood sugar over 2-3 months), fasting blood glucose, and insulin resistance. They then looked for "subclinical" cardiovascular disease - meaning early structural changes to the heart and blood vessels that occur before a person experiences symptoms like chest pain or shortness of breath.

The findings revealed a clear pattern: as blood sugar markers worsened, so did early signs of heart disease. People with higher HbA1C levels showed more calcium buildup in their coronary arteries, thicker carotid artery walls, and enlarged heart muscle. Similarly, those with higher fasting glucose levels had increased heart muscle mass and more arterial changes. Even insulin resistance alone - when cells don't respond properly to insulin - was associated with heart muscle enlargement and reduced blood flow to the legs.

What makes this research particularly significant is that it demonstrates how blood sugar problems begin affecting the cardiovascular system long before diabetes is diagnosed or heart disease symptoms appear. This suggests that even modest elevations in blood sugar - levels that might be considered "pre-diabetic" or "borderline" - are already causing measurable changes to the heart and blood vessels.

For those focused on metabolic health and longevity, this study underscores the importance of maintaining optimal blood sugar control throughout life, not just avoiding diabetes. In clinical practice, this research supports regular monitoring of HbA1C, fasting glucose, and insulin sensitivity as part of comprehensive cardiovascular risk assessment, particularly for early intervention strategies.